(435) 292-5548
 Medicare News
Home  ›  Prescription Assistance  ›  Nexlizet

Cholesterol · Heart & Blood Pressure

Nexlizet Assistance Programs & Grants

Assistance information last verified: August 2026

AltaMedicare is an independent Medicare agency in Alpine, Utah, founded by Bret Swope, a licensed Medicare agent. We provide educational, no-pressure help comparing Medicare Advantage, Medigap (Medicare Supplement), and Part D at no cost, serving the entire state of Utah. Call or text (435) 292-5548.

Manufacturer programs, charitable grants and Medicare routes for Nexlizet (bempedoic acid / ezetimibe) — each checked on its official source.

Can I get help paying for Nexlizet?

Yes — and unusually for this batch, through a fund that was actually open. TotalAssist's Hypercholesterolemia fund was accepting applications on August 26, 2026, lists Nexlizet by name, and pays a $1,900 guaranteed award up to $3,800. Esperion itself offers a Medicare beneficiary nothing: its co-pay card excludes Medicare and it publishes no patient assistance program.

  • TotalAssist Hypercholesterolemia fund: OPEN on August 26, 2026. $1,900 guaranteed, $3,800 maximum, for people with Medicare, Medicaid or TRICARE and income at or below 500% of the federal poverty level adjusted for local cost of living. Nexlizet is on its approved-medication list.
  • NEXLIZET & NEXLETOL Co-Pay Card: one card covering both products, commercial insurance only. Esperion's terms exclude "Medicare, Medicaid, Medigap, TRICARE... or the Department of Veterans Affairs (VA) healthcare program".
  • No manufacturer patient assistance program: nothing on Esperion's published support pages gives Nexlizet away on an income test. Recorded as a negative finding, not an omission.
  • The arithmetic worth running: half of Nexlizet is ezetimibe, a cheap generic. Ask your prescriber and plan whether Nexletol plus separate generic ezetimibe costs less than the combination tablet.
  • HealthWell Hypercholesterolemia – Medicare Access fund: lists Nexlizet, $2,500 maximum, but was closed to new patients. Sign up for its alerts.
  • Not a Medicare-negotiated drug for 2026, 2027 or 2028; Part D costs capped at $2,100 in 2026; Extra Help can cut a covered brand copay to about $12.65.

2 of the 5 programs we checked for Nexlizet were accepting applications when verified in August 2026.

About Nexlizet (bempedoic acid / ezetimibe)

Nexlizet is a single tablet combining two cholesterol medicines: bempedoic acid, which blocks an enzyme the liver uses to make cholesterol a step above where statins act, and ezetimibe, which reduces how much cholesterol your gut absorbs. That two-in-one construction is exactly what makes its cost question different from Nexletol's, because one of the two ingredients has been generic for years.

Approved uses

  • Lowering LDL cholesterol, alongside diet, in adults with hypercholesterolemia — including heterozygous familial hypercholesterolemia — used with other LDL-lowering therapies or alone when they are not possible

Manufacturer: Esperion Therapeutics

Why Nexlizet can be expensive on Medicare

Nexlizet is a brand-only tablet with no generic combination — DailyMed labels only Esperion's product — and Part D plans generally place it on a brand tier, often behind step therapy asking you to try a statin first, which is frequently the very thing a Nexlizet candidate could not tolerate. What makes its cost picture unusual is the composition: half of Nexlizet is ezetimibe, an inexpensive generic available on its own. So the brand-tier price you are being charged covers one ingredient that has no alternative and one that does.

Medicare coverage context

Nexlizet is a tablet you take yourself, so Medicare covers it under Part D or a Medicare Advantage drug plan, usually on a brand tier with step therapy. It is not a Medicare-negotiated drug: CMS's selected-drug and Maximum Fair Price file has no Nexlizet, Nexletol or bempedoic acid row for 2026, 2027 or 2028. Esperion publishes no patient assistance program that gives Nexlizet away on an income test, and its co-pay card excludes Medicare by name — so for a Part D beneficiary the manufacturer offers no route at all. That makes the charitable and Medicare-side options the whole picture, and fortunately one of them was open when we checked. Part D out-of-pocket costs are capped at $2,100 in 2026, and Extra Help lowers cost-sharing for people with limited income and resources.

Check typical Part D coverage · Estimate your drug costs · Compare Part D drug plans

Nexlizet assistance options at a glance

Every program we checked, what kind of help it is, whether people with Medicare can use it, and its status when we verified it. A medication being listed by a program is not the same as the program accepting applications.

About the income limits below: Income limits can differ between assistance programs even when both describe their eligibility as the same percentage of the federal poverty level. The dollar limits shown here come from each program's own published income table, and each program decides which year's poverty guidelines that table is built from and when it takes effect. Treat the figures as belonging to the program they are listed under — they are not interchangeable, and only the program can tell you which table it is applying to your application today.

Nexlizet assistance programs compared
ProgramType of helpPeople with MedicareStatus (August 2026)
TotalAssist — Hypercholesterolemia fund Charitable grant may apply Accepting applications
HealthWell Foundation — Hypercholesterolemia – Medicare Access fund Charitable grant may apply Closed to new applicants
NEXLIZET & NEXLETOL Co-Pay Card Commercial copay / savings card not eligible Accepting applications
Esperion patient assistance program — none found Manufacturer patient assistance not stated No program found
Good Days — no applicable fund Charitable grant not stated No program found
Medicare Extra Help (Part D Low-Income Subsidy) Government program may apply Accepting applications

Manufacturer programs from Esperion Therapeutics

A patient assistance program (free or low-cost drug by income) is not the same as a copay card (a commercial discount that usually excludes Medicare). Both are listed so you can see which one applies to you.

Commercial copay / savings card

NEXLIZET & NEXLETOL Co-Pay Card

Esperion Therapeutics

Accepting applications Medicare: not eligible

Status: Active for commercially insured patients on August 26, 2026. One card covers both Nexlizet and Nexletol. Enrolment lasts one year and must be renewed annually; Esperion determines final eligibility.

A commercial copay offer at "as little as $10 per fill", covering both Esperion products on a single card. Firmly closed to Medicare, which is why the open TotalAssist fund above carries the weight on this page.

If you have Medicare: Esperion's terms are among the strictest in this registry. A patient may be eligible only if "not enrolled in any state-, federal-, or government-funded healthcare program, including but not limited to Medicare, Medicaid, Medigap, TRICARE of the Department of Defense, or the Department of Veterans Affairs (VA) healthcare program." The terms add that a patient enrolled in such a program may not use the card "even if they elect to be processed as a commercial or discount insurance plan patient", and that anyone who joins one mid-enrolment must report it and loses eligibility. There is no workaround.

What it can cover: Part of the commercial copay for Nexlizet or Nexletol. Not applicable to Medicare cost-sharing.

Who may qualify

  • Commercial (private or employer-sponsored) prescription insurance covering Nexlizet
  • Not enrolled in any state, federal or government-funded healthcare program, including Medicare, Medicaid, Medigap, TRICARE or VA
  • Enrolment lasts one year and must be renewed

How to apply

Commercially insured patients enrol through the co-pay card program. Medicare beneficiaries should apply to the TotalAssist Hypercholesterolemia fund instead — it was open when we checked.

Co-Pay Card terms and conditions → 855-699-8814

Manufacturer patient assistance

Esperion patient assistance program — none found

Esperion Therapeutics

No program found Medicare: not stated

Status: On August 26, 2026 the patient support Esperion publishes for Nexlizet is the NEXSTEP program — a Co-Pay Card for commercially insured patients and a NEXSTEP Navigator access service reached through an Esperion representative. No income-based program supplying Nexlizet free of charge appears on those pages.

An honest negative. Many brand medicines have a manufacturer program that gives the drug away under an income limit; for Nexlizet we could not find one. That absence is precisely why the open TotalAssist fund matters so much here, and why the two-tablet arithmetic below is worth running.

If you have Medicare: Not applicable — we found no manufacturer patient assistance program for Nexlizet to state a Medicare rule. If Esperion adds one, it would appear on the NEXSTEP support pages cited here.

How to apply

Not applicable. If Esperion adds a patient assistance program it would appear on the access and savings pages cited here.

Esperion access and savings → 1-833-377-7633

Charitable grants for Nexlizet

This is one of the better charitable pictures in the whole expansion, and it is worth acting on rather than filing away. TotalAssist's Hypercholesterolemia fund was OPEN on August 26, 2026 — accepting applications, with a $1,900 guaranteed award and a $3,800 maximum — and "Nexlizet (Bempedoic Acid/Ezetimibe)" is named on its approved-medication list. It requires government insurance, which means Medicare beneficiaries are exactly who it is for. HealthWell's Hypercholesterolemia – Medicare Access fund also covers Nexlizet, at up to $2,500, but was closed to new patients; set its alerts as a second option. Good Days has no cholesterol fund. Because Esperion offers a Medicare beneficiary nothing — its co-pay card excludes Medicare and it publishes no patient assistance program — the open fund is not a supplement to the manufacturer route here. It is the route.

Charitable grant

TotalAssist — Hypercholesterolemia fund

Patient Advocate Foundation · Hypercholesterolemia

Accepting applications Medicare: may apply

Status: ACCEPTING APPLICATIONS on August 26, 2026, with a $1,900 guaranteed award and a $3,800 maximum. This is one of very few open funds encountered anywhere in this expansion, so it is the first thing to act on rather than the last.

"Nexlizet (Bempedoic Acid/Ezetimibe)" is named on the approved-medication list, alongside Nexletol, plain ezetimibe, Leqvio, Praluent, the Repatha products and a long list of statins. Because it was open, an application can produce a decision immediately rather than a wait for a fund to reopen.

If you have Medicare: This fund requires government-insured coverage — Medicare, Medicaid or TRICARE — that covers your qualifying expenses. Medicare beneficiaries are not merely permitted here; government insurance is a condition of eligibility. Given that Esperion's own co-pay card excludes Medicare, this fund is the route that exists precisely for the readers the manufacturer turns away.

What it can cover: $1,900 guaranteed award and up to $3,800 maximum for medication copays, coinsurance, deductibles and health-insurance premiums. One grant per condition.

Who may qualify

  • Confirmed hypercholesterolemia diagnosis, in treatment, starting within 60 days, or treated in the past 6 months
  • Government-insured coverage (Medicare, Medicaid or TRICARE) that covers your qualifying expenses
  • Household income at or below 500% of the federal poverty level, adjusted for your regional cost-of-living index
  • Confirmed diagnosis matching the fund, and in treatment (or starting within 60 days, or treated in the past 6 months)
  • Legal U.S. resident receiving treatment in the U.S. or a U.S. territory

What the application asks for

  • Contact information and Social Security number (or alien number)
  • Annual household income (for pre-screening; proof of income due within 30 days of approval)
  • Health insurance carrier, plan type, policy ID and group number; Medicare supplement or secondary insurance if you have one
  • Copay or coinsurance amounts
  • Your provider's name and contact information, diagnosis (exact date if within 6 months), prescribed medications and treatment plan

How to apply

You (the patient) apply online — it takes about 15 minutes and you learn immediately whether you are approved — or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis and treatment plan directly with your provider and verifies income automatically; you have 30 days after approval to provide proof of income.

Apply to the TotalAssist Hypercholesterolemia fund → 866-512-3861

Charitable grant

HealthWell Foundation — Hypercholesterolemia – Medicare Access fund

HealthWell Foundation · Hypercholesterolemia – Medicare Access

Closed to new applicants Medicare: may apply

Status: Closed to new patients on August 26, 2026, with a $2,500 maximum award when open. Nexletol, Nexlizet and bempedoic acid are all on its covered list.

A Medicare-specific cholesterol fund that covers Nexlizet, closed when we checked. Worth an alert alongside the open TotalAssist fund, since the two have different award structures and you may prefer one.

If you have Medicare: This is a Medicare-only fund — built specifically for Medicare beneficiaries, with a 500% federal poverty level income test. It was closed when we checked, but its alerts are worth setting because a second cholesterol fund reopening would give you a choice of two.

What it can cover: When open: up to $2,500 for copays, coinsurance, deductibles and health-insurance premiums for hypercholesterolemia.

Who may qualify

  • A confirmed hypercholesterolemia diagnosis, verified by your prescriber
  • Medicare coverage — this is a Medicare Access fund
  • Income at or below 500% of the federal poverty level
  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

What the application asks for

  • Some form of health insurance (Medicare qualifies) that covers part of the cost of the drug — discount cards do not count
  • Social Security number (used to prevent duplicate applications)
  • Diagnosis verified by a physician's, nurse practitioner's or physician assistant's signature
  • Treatment in the United States

How to apply

When a fund is open, apply online or by phone; your provider verifies the diagnosis by signature. When a fund is closed, sign up for that fund's real-time alerts — HealthWell says replenished funds reopen "as quickly as possible."

HealthWell Hypercholesterolemia fund and alerts → (800) 675-8416

Charitable grant

Good Days — no applicable fund

Good Days

No program found Medicare: not stated

Status: Good Days' published disease list on August 26, 2026 contained 57 programs and none of them was hypercholesterolemia or any cholesterol condition.

An honest negative, checked so you do not spend time on a third foundation that has no fund for you.

If you have Medicare: Good Days accepts Medicare beneficiaries for the diseases it covers, but it covers no diagnosis that applies to Nexlizet.

How to apply

Not applicable today. The diseases-covered page shows every fund Good Days runs.

Good Days diseases covered →

How to apply for Nexlizet assistance

  1. Step 1 — Find the applicable assistance program

    For Nexlizet on Medicare in August 2026 there is an open fund, which changes the usual order entirely:

    • Apply to the TotalAssist Hypercholesterolemia fund now. It was open, it lists Nexlizet, and it gives an immediate decision.
    • Limited income and resources → Medicare Extra Help through Social Security, which you can hold alongside the fund.
    • Run the two-tablet arithmetic: ask your prescriber and plan whether Nexletol plus separate generic ezetimibe costs less than the Nexlizet combination.
    • Set alerts on the HealthWell Hypercholesterolemia – Medicare Access fund as a second option.
    • Do not spend time on Esperion — its co-pay card excludes Medicare and it publishes no patient assistance program.

  2. Step 2 — Check whether applications are currently open

    One fund was open and one was closed — an unusual position in this batch, and worth confirming before you apply.

    • TotalAssist Hypercholesterolemia: OPEN when we checked. Fund pages show "Open" or "Closed" and current award amounts, and status can change quickly.
    • HealthWell Hypercholesterolemia – Medicare Access: closed to new patients. Sign up for real-time alerts.
    • Esperion: no patient assistance program to check. The NEXSTEP pages are the place a new one would appear.

  3. Step 3 — Check eligibility

    The open fund's rules are the ones that matter most here:

    • TotalAssist: government insurance (Medicare, Medicaid or TRICARE) covering Nexlizet; income at or below 500% of the federal poverty level adjusted for your regional cost-of-living index; a confirmed hypercholesterolemia diagnosis in treatment, starting within 60 days, or treated in the past 6 months.
    • HealthWell (when open): Medicare coverage, income at or below 500% of the federal poverty level, and a prescriber-verified diagnosis.
    • Extra Help: income below about $23,940 a year for one person or $32,460 for a couple, and countable resources limited to $18,090 or $36,100 in 2026.
    • Esperion Co-Pay Card: commercial insurance only, with Medicare, Medicaid, Medigap, TRICARE and VA all excluded — and no processing workaround permitted.

  4. Step 4 — Gather your information

    TotalAssist gives an immediate online decision, so having these to hand lets you finish in one sitting:

    • Contact information and Social Security number.
    • Annual household income for pre-screening — proof is due within 30 days of approval, not upfront.
    • Health insurance carrier, plan type, policy ID and group number, plus any Medicare supplement or secondary insurance.
    • Your copay or coinsurance amount for Nexlizet.
    • Your provider's name and contact details, your hypercholesterolemia diagnosis and its date, and your prescribed medications.

  5. Step 5 — Complete the application

    Who fills out what:

    • TotalAssist: you apply online in about 15 minutes and learn immediately whether you are approved, or call 866-512-3861, Monday–Friday 8:30am–5:30pm ET. Patient Advocate Foundation verifies your diagnosis with your provider.
    • HealthWell (when open): apply online or by phone; your provider verifies the diagnosis by signature.
    • Extra Help: you (or someone helping you) apply free through Social Security — online, by phone on 1-800-772-1213, or at an office. There is never a fee.
    • Two-tablet switch: nothing to apply for — a prescribing and formulary question.

  6. Step 6 — Submit and wait for a determination

    What to expect:

    • TotalAssist: an immediate online decision, with proof of income due within 30 days of approval.
    • HealthWell (when open): a decision once your provider returns the diagnosis verification.
    • Extra Help: Social Security notifies you by mail; your Part D plan then applies the lower copays.

  7. Step 7 — If the program is closed or you don't qualify

    The composition of this tablet gives you an option most brand medicines do not:

    • Ask whether Nexletol plus separate generic ezetimibe would cost less than Nexlizet. Half of Nexlizet is a long-established generic, and taking the two ingredients separately is sometimes cheaper on a formulary — this is a prescribing conversation, but a legitimate one.
    • Ask your prescriber's office about a formulary exception if step therapy is the barrier — many Nexlizet candidates are prescribed it precisely because they could not tolerate a statin.
    • Apply for Extra Help even if you assume you earn too much; the limits are higher than most people expect.
    • Do not wait for a generic — no generic bempedoic acid exists in any form, so the combination is not going generic soon.
    • Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments.
    • Call AltaMedicare — we will work through every route above with you, free.

What you'll need

Only items the programs above actually ask for. Gather these before you start.

  • Medicare card and your Part D or Medicare Advantage drug-plan card — plan name, member ID and group number
  • Prescription details — medication name, strength and dose; prescriber name, office phone and address
  • Diagnosis and date of diagnosis — TotalAssist needs the exact date if diagnosed within the past 6 months
  • Household size and annual household income — and proof — tax return, Social Security or pension statements, or pay stubs
  • Your copay or coinsurance amount for Nexlizet — TotalAssist asks for it on the application, and you need it for the two-tablet comparison too
  • What your plan charges for Nexletol and for generic ezetimibe separately — the comparison that decides whether the combination tablet is worth its brand tier

If assistance is unavailable

A closed fund or a denial is not the end of the road. Check these next:

  1. Ask your prescriber and plan whether Nexletol plus separate generic ezetimibe costs less than the Nexlizet combination tablet. Half of Nexlizet has been generic for years, and the two-tablet route is sometimes cheaper on a formulary.
  2. Apply to the TotalAssist Hypercholesterolemia fund — it was accepting applications when we checked, gives an immediate decision, and requires government insurance rather than excluding it. TotalAssist Hypercholesterolemia fund
  3. Sign up for TotalAssist fund notifications so you hear the moment a Nexlizet fund reopens — there is no waitlist or queue, so speed matters. TotalAssist notifications
  4. Sign up for HealthWell fund alerts for the same reason; HealthWell says closed funds reopen as funding is replenished. HealthWell disease funds
  5. Check Medicare Extra Help — it does not depend on a fund balance and lowers the cost of every covered drug, not just this one. Medicare Extra Help explained
  6. Ask your doctor's office — many practices have staff who handle assistance applications routinely and can request a formulary exception or a lower-cost alternative.
  7. Use the Medicare Prescription Payment Plan to spread this year's out-of-pocket costs across monthly payments (it does not lower the total). Medicare.gov
  8. Compare Part D and Medicare Advantage drug plans during the fall enrollment period — the tier and cost-sharing for Nexlizet differ from plan to plan. Compare Part D plan options

Could Medicare Extra Help reduce your Nexlizet costs?

Extra Help is not a grant for Nexlizet. It is a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription — so it is worth checking even when a charitable fund is closed, because it does not depend on fund balances.

Extra Help carries full weight for Nexlizet because there is no manufacturer program to weigh it against. There is no conflict to manage and nothing to choose between: if your income and resources are limited, apply. With full Extra Help a covered brand-name drug costs about $12.65 in 2026. Extra Help and the TotalAssist fund can also be held together — the fund requires government insurance rather than excluding subsidy holders — so pursue both.

In 2026, people with full Extra Help generally pay no more than $12.65 for a covered brand-name drug. Income must be below about $23,940 a year for one person ($32,460 for a couple) and countable resources under $18,090 ($36,100 for a couple). Apply free through Social Security — online, by phone at 1-800-772-1213, or in person — and never pay anyone to apply for you.

Extra Help explained · Medicare Savings Programs · Estimate your drug costs · Free prescription cost review

Government program

Medicare Extra Help (Part D Low-Income Subsidy)

Medicare / Social Security Administration

Accepting applications Medicare: may apply

Status: Year-round federal program (figures for 2026)

Not a grant for one drug — a Medicare program that lowers what qualifying beneficiaries pay for their Part D premium, deductible and every covered prescription.

If you have Medicare: For people with Medicare Part D or a Medicare Advantage drug plan who have limited income and resources.

What it can cover: Part D premium and deductible (often to $0) and reduced copays — generally no more than $12.65 for a covered brand-name drug in 2026 with full Extra Help.

Who may qualify

  • Income below 150% of the federal poverty level — about $23,940 a year for one person or $32,460 for a married couple in 2026.
  • Countable resources (savings, investments — not your home or car) limited to $18,090 for an individual or $36,100 for a married couple living together in 2026 (Medicare.gov figures, which include a burial-expense allowance).
  • Automatic if you have Medicaid, Supplemental Security Income (SSI), or a Medicare Savings Program.

What the application asks for

  • Social Security number and Medicare number
  • Income (Social Security, pensions, wages) for you and a spouse you live with
  • Value of savings, investments and other countable resources

How to apply

You (or someone helping you) apply free through Social Security — online, by phone, or at a Social Security office. There is never a fee to apply.

Apply for Extra Help at SSA.gov → 1-800-772-1213

Key terms on this page

Patient assistance program (PAP)
A manufacturer program that provides its medication free or at low cost to people who meet income and insurance rules. Many PAPs accept Medicare Part D enrollees; each sets its own criteria.
Copay card / savings card
A manufacturer discount for commercially insured patients. Federal anti-kickback rules mean these cards generally cannot be used with Medicare, Medicaid or other government insurance.
Charitable copay grant
Money from a nonprofit foundation (for example HealthWell or Patient Advocate Foundation) that pays eligible copays or coinsurance for a specific diagnosis. A drug can be listed while the fund is closed to new applicants.
Federal poverty level (FPL)
A federal income measure that assistance programs use as a yardstick — "300% of FPL", "500% of FPL". The percentage is a rule, but the dollar figure behind it comes from a table each program publishes itself, built on a chosen year of the HHS poverty guidelines. Two programs can quote the same percentage in the same year and still list different dollar limits; compare each program against its own table, not against another program.
Medicare Extra Help
The Part D Low-Income Subsidy: a Medicare program that lowers or eliminates Part D premiums, deductibles and copays for beneficiaries with limited income and resources. You apply through Social Security.
Maximum Fair Price (MFP)
The price Medicare negotiated for a selected drug under the Medicare Drug Price Negotiation Program. It applies to Part D plans, not to the pharmacy cash price, and it lowers what plans and enrollees pay for that drug.

Related medication assistance guides

Nexletol Assistance & Grants bempedoic acid Leqvio Assistance & Grants inclisiran Praluent Assistance & Grants alirocumab Repatha Assistance & Grants evolocumab All prescription assistance Directory & program finder
Common Questions

Nexlizet assistance FAQ

Does Medicare cover Nexlizet?
Yes — Medicare Part D and Medicare Advantage drug plans generally cover Nexlizet, usually on a brand tier and often behind step therapy that asks you to try a statin first. Part D out-of-pocket costs are capped at $2,100 in 2026. If your income and resources are limited, Medicare Extra Help can bring a covered brand-name copay to about $12.65.
Is there a Nexlizet patient assistance program for people on Medicare?
Not from Esperion. Its published support for Nexlizet is the NEXSTEP program — a co-pay card for commercially insured patients and a Navigator access service — and no income-based program that supplies Nexlizet free of charge appears on those pages. The co-pay card excludes Medicare explicitly. For a Medicare beneficiary the route that does exist is charitable: TotalAssist's Hypercholesterolemia fund was open when we checked, lists Nexlizet, and pays $1,900 guaranteed up to $3,800.
Would taking Nexletol and ezetimibe separately be cheaper than Nexlizet?
It is worth asking, and the question only arises because of how Nexlizet is made. Nexlizet combines bempedoic acid — which is brand-only, with no generic in any form — and ezetimibe, which has been generic for years and appears on the TotalAssist fund list in its own right. Some Part D formularies price the brand combination higher than a brand tablet plus a generic tablet taken separately, and some do not. Ask your prescriber whether splitting them is clinically appropriate for you, and ask your plan what each option would cost. It is a genuine arithmetic question rather than a certainty either way.
Can I use the Nexlizet co-pay card with Medicare?
No, and Esperion's terms leave no room. A patient may be eligible only if "not enrolled in any state-, federal-, or government-funded healthcare program, including but not limited to Medicare, Medicaid, Medigap, TRICARE of the Department of Defense, or the Department of Veterans Affairs (VA) healthcare program." The terms go further than most: a patient enrolled in such a program may not use the card "even if they elect to be processed as a commercial or discount insurance plan patient", and anyone who joins one mid-enrolment must report it and loses eligibility.
Is there a charitable grant for Nexlizet right now?
Yes — this is one of the few medications in this batch where the answer is a straightforward yes. TotalAssist's Hypercholesterolemia fund was accepting applications on August 26, 2026, lists "Nexlizet (Bempedoic Acid/Ezetimibe)" on its approved-medication list, and pays a $1,900 guaranteed award up to $3,800. It requires government insurance — Medicare, Medicaid or TRICARE — so Medicare beneficiaries are exactly who it is designed for. HealthWell's Hypercholesterolemia – Medicare Access fund also covers Nexlizet, at up to $2,500, but was closed to new patients.
Is Nexlizet part of Medicare drug price negotiation?
No. CMS's selected-drug and Maximum Fair Price file has no Nexlizet, Nexletol or bempedoic acid row for initial price applicability year 2026, 2027 or 2028. Your cost is set by your plan's tier and cost-sharing, and by whether a charitable grant or Extra Help is covering part of it. See all prescription assistance options.

Sources

Related resources

Assistance information last verified August 2026. Program details — fund status, eligibility, prices, phone numbers — change often; confirm with each program before applying. AltaMedicare does not administer, fund or approve any assistance program. Not medical advice.

Having trouble figuring out your prescription costs?

Bret can help you understand your Medicare prescription coverage and where to look for Nexlizet assistance — free, no pressure. We don't award grants or decide eligibility; the programs above do. We help you find and apply to the right ones.

Text Bret About Nexlizet Call (435) 292-5548